Global Anticoagulants Market Growth 2020-2025

Publication Month: Feb 2020 | No. of Pages: 158 Published By: LP Information
Single User License: US $ 3660
Team User License: US $ 7320

According to this study, over the next five years the Anticoagulants market will register a 9.3% CAGR in terms of revenue, the global market size will reach $ 1237.2 million by 2025, from $ 865.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoagulants business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulants market by type, application, key manufacturers and key regions and countries.

This study considers the Anticoagulants value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
VTE
ACS/MI
AF
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Otsuka
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Aspen
AstraZeneca
Lilly
Bristol-Myers Squibb
Pfizer
The Medicines Company
Daiichi Sankyo

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anticoagulants consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Anticoagulants market by identifying its various subsegments.
Focuses on the key global Anticoagulants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anticoagulants with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anticoagulants submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticoagulants Consumption 2015-2025
2.1.2 Anticoagulants Consumption CAGR by Region
2.2 Anticoagulants Segment by Type
2.2.1 Platelet aggregation inhibitors (PAI)
2.2.2 Low-molecular-weight Heparin (LMWH)
2.2.3 Direct thrombin inhibitor (DTI)
2.2.4 Direct factor Xa inhibitors (DFXa)
2.2.5 Vitamin K antagonists (VKA)
2.2.6 Others
2.3 Anticoagulants Consumption by Type
2.3.1 Global Anticoagulants Consumption Market Share by Type (2015-2020)
2.3.2 Global Anticoagulants Revenue and Market Share by Type (2015-2020)
2.3.3 Global Anticoagulants Sale Price by Type (2015-2020)
2.4 Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Other
2.5 Anticoagulants Consumption by Application
2.5.1 Global Anticoagulants Consumption Market Share by Type (2015-2020)
2.5.2 Global Anticoagulants Value and Market Share by Type (2015-2020)
2.5.3 Global Anticoagulants Sale Price by Type (2015-2020)

3 Global Anticoagulants by Company
3.1 Global Anticoagulants Sales Market Share by Company
3.1.1 Global Anticoagulants Sales by Company (2018-2020)
3.1.2 Global Anticoagulants Sales Market Share by Company (2018-2020)
3.2 Global Anticoagulants Revenue Market Share by Company
3.2.1 Global Anticoagulants Revenue by Company (2018-2020)
3.2.2 Global Anticoagulants Revenue Market Share by Company (2018-2020)
3.3 Global Anticoagulants Sale Price by Company
3.4 Global Anticoagulants Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Anticoagulants Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Anticoagulants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anticoagulants by Regions
4.1 Anticoagulants by Regions
4.2 Americas Anticoagulants Consumption Growth
4.3 APAC Anticoagulants Consumption Growth
4.4 Europe Anticoagulants Consumption Growth
4.5 Middle East & Africa Anticoagulants Consumption Growth

5 Americas
5.1 Americas Anticoagulants Consumption by Countries
5.1.1 Americas Anticoagulants Consumption by Countries (2015-2020)
5.1.2 Americas Anticoagulants Value by Countries (2015-2020)
5.2 Americas Anticoagulants Consumption by Type
5.3 Americas Anticoagulants Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Anticoagulants Consumption by Regions
6.1.1 APAC Anticoagulants Consumption by Regions (2015-2020)
6.1.2 APAC Anticoagulants Value by Regions (2015-2020)
6.2 APAC Anticoagulants Consumption by Type
6.3 APAC Anticoagulants Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Anticoagulants by Countries
7.1.1 Europe Anticoagulants Consumption by Countries (2015-2020)
7.1.2 Europe Anticoagulants Value by Countries (2015-2020)
7.2 Europe Anticoagulants Consumption by Type
7.3 Europe Anticoagulants Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Anticoagulants by Countries
8.1.1 Middle East & Africa Anticoagulants Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Anticoagulants Value by Countries (2015-2020)
8.2 Middle East & Africa Anticoagulants Consumption by Type
8.3 Middle East & Africa Anticoagulants Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anticoagulants Distributors
10.3 Anticoagulants Customer

11 Global Anticoagulants Market Forecast
11.1 Global Anticoagulants Consumption Forecast (2021-2025)
11.2 Global Anticoagulants Forecast by Regions
11.2.1 Global Anticoagulants Forecast by Regions (2021-2025)
11.2.2 Global Anticoagulants Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Anticoagulants Forecast by Type
11.8 Global Anticoagulants Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Anticoagulants Product Offered
12.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Otsuka
12.2.1 Company Information
12.2.2 Anticoagulants Product Offered
12.2.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Otsuka Latest Developments
12.3 Bayer
12.3.1 Company Information
12.3.2 Anticoagulants Product Offered
12.3.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Anticoagulants Product Offered
12.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Genentech (Roche)
12.5.1 Company Information
12.5.2 Anticoagulants Product Offered
12.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Genentech (Roche) Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Company Information
12.6.2 Anticoagulants Product Offered
12.6.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Aspen
12.7.1 Company Information
12.7.2 Anticoagulants Product Offered
12.7.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Aspen Latest Developments
12.8 AstraZeneca
12.8.1 Company Information
12.8.2 Anticoagulants Product Offered
12.8.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 AstraZeneca Latest Developments
12.9 Lilly
12.9.1 Company Information
12.9.2 Anticoagulants Product Offered
12.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Lilly Latest Developments
12.10 Bristol-Myers Squibb
12.10.1 Company Information
12.10.2 Anticoagulants Product Offered
12.10.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bristol-Myers Squibb Latest Developments
12.11 Pfizer
12.11.1 Company Information
12.11.2 Anticoagulants Product Offered
12.11.3 Pfizer Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Pfizer Latest Developments
12.12 The Medicines Company
12.12.1 Company Information
12.12.2 Anticoagulants Product Offered
12.12.3 The Medicines Company Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 The Medicines Company Latest Developments
12.13 Daiichi Sankyo
12.13.1 Company Information
12.13.2 Anticoagulants Product Offered
12.13.3 Daiichi Sankyo Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Daiichi Sankyo Latest Developments

13 Research Findings and Conclusion

Tables and Figures

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Anticoagulants Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Platelet aggregation inhibitors (PAI)
Table 5. Major Players of Low-molecular-weight Heparin (LMWH)
Table 6. Major Players of Direct thrombin inhibitor (DTI)
Table 7. Major Players of Direct factor Xa inhibitors (DFXa)
Table 8. Major Players of Vitamin K antagonists (VKA)
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Anticoagulants Consumption Market Share by Type (2015-2020)
Table 12. Global Anticoagulants Revenue by Type (2015-2020) ($ million)
Table 13. Global Anticoagulants Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Anticoagulants Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Anticoagulants Consumption Market Share by Application (2015-2020)
Table 17. Global Anticoagulants Value by Application (2015-2020)
Table 18. Global Anticoagulants Value Market Share by Application (2015-2020)
Table 19. Global Anticoagulants Sale Price by Application (2015-2020)
Table 20. Global Anticoagulants Sales by Company (2017-2019) (K MT)
Table 21. Global Anticoagulants Sales Market Share by Company (2017-2019)
Table 22. Global Anticoagulants Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Anticoagulants Revenue Market Share by Company (2017-2019)
Table 24. Global Anticoagulants Sale Price by Company (2017-2019)
Table 25. Global Anticoagulants Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Anticoagulants Products Offered
Table 27. Anticoagulants Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Anticoagulants Consumption by Regions 2015-2020 (K MT)
Table 29. Global Anticoagulants Consumption Market Share by Regions 2015-2020
Table 30. Global Anticoagulants Value by Regions 2015-2020 ($ Millions)
Table 31. Global Anticoagulants Value Market Share by Regions 2015-2020
Table 32. Americas Anticoagulants Consumption by Countries (2015-2020) (K MT)
Table 33. Americas Anticoagulants Consumption Market Share by Countries (2015-2020)
Table 34. Americas Anticoagulants Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Anticoagulants Value Market Share by Countries (2015-2020)
Table 36. Americas Anticoagulants Consumption by Type (2015-2020) (K MT)
Table 37. Americas Anticoagulants Consumption Market Share by Type (2015-2020)
Table 38. Americas Anticoagulants Consumption by Application (2015-2020) (K MT)
Table 39. Americas Anticoagulants Consumption Market Share by Application (2015-2020)
Table 40. APAC Anticoagulants Consumption by Countries (2015-2020) (K MT)
Table 41. APAC Anticoagulants Consumption Market Share by Countries (2015-2020)
Table 42. APAC Anticoagulants Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Anticoagulants Value Market Share by Regions (2015-2020)
Table 44. APAC Anticoagulants Consumption by Type (2015-2020) (K MT)
Table 45. APAC Anticoagulants Consumption Market Share by Type (2015-2020)
Table 46. APAC Anticoagulants Consumption by Application (2015-2020) (K MT)
Table 47. APAC Anticoagulants Consumption Market Share by Application (2015-2020)
Table 48. Europe Anticoagulants Consumption by Countries (2015-2020) (K MT)
Table 49. Europe Anticoagulants Consumption Market Share by Countries (2015-2020)
Table 50. Europe Anticoagulants Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Anticoagulants Value Market Share by Countries (2015-2020)
Table 52. Europe Anticoagulants Consumption by Type (2015-2020) (K MT)
Table 53. Europe Anticoagulants Consumption Market Share by Type (2015-2020)
Table 54. Europe Anticoagulants Consumption by Application (2015-2020) (K MT)
Table 55. Europe Anticoagulants Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Anticoagulants Consumption by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Anticoagulants Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Anticoagulants Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Anticoagulants Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Anticoagulants Consumption by Type (2015-2020) (K MT)
Table 61. Middle East & Africa Anticoagulants Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Anticoagulants Consumption by Application (2015-2020) (K MT)
Table 63. Middle East & Africa Anticoagulants Consumption Market Share by Application (2015-2020)
Table 64. Anticoagulants Distributors List
Table 65. Anticoagulants Customer List
Table 66. Global Anticoagulants Consumption Forecast by Countries (2021-2025) (K MT)
Table 67. Global Anticoagulants Consumption Market Forecast by Regions
Table 68. Global Anticoagulants Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Anticoagulants Value Market Share Forecast by Regions
Table 70. Global Anticoagulants Consumption Forecast by Type (2021-2025) (K MT)
Table 71. Global Anticoagulants Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Anticoagulants Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Anticoagulants Value Market Share Forecast by Type (2021-2025)
Table 74. Global Anticoagulants Consumption Forecast by Application (2021-2025) (K MT)
Table 75. Global Anticoagulants Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Anticoagulants Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Anticoagulants Value Market Share Forecast by Application (2021-2025)
Table 78. Sanofi Product Offered
Table 79. Sanofi Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Sanofi Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 83. Otsuka Product Offered
Table 84. Otsuka Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 85. Otsuka Main Business
Table 86. Otsuka Latest Developments
Table 87. Otsuka Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Product Offered
Table 89. Bayer Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. Bayer Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Product Offered
Table 94. Johnson & Johnson Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 98. Genentech (Roche) Product Offered
Table 99. Genentech (Roche) Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 100. Genentech (Roche) Main Business
Table 101. Genentech (Roche) Latest Developments
Table 102. Genentech (Roche) Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Product Offered
Table 104. Boehringer Ingelheim Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 105. Boehringer Ingelheim Main Business
Table 106. Boehringer Ingelheim Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 108. Aspen Product Offered
Table 109. Aspen Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 110. Aspen Main Business
Table 111. Aspen Latest Developments
Table 112. Aspen Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 113. AstraZeneca Product Offered
Table 114. AstraZeneca Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. AstraZeneca Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 118. Lilly Product Offered
Table 119. Lilly Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 120. Lilly Main Business
Table 121. Lilly Latest Developments
Table 122. Lilly Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 123. Bristol-Myers Squibb Product Offered
Table 124. Bristol-Myers Squibb Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 125. Bristol-Myers Squibb Main Business
Table 126. Bristol-Myers Squibb Latest Developments
Table 127. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 128. Pfizer Product Offered
Table 129. Pfizer Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 130. Pfizer Main Business
Table 131. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Pfizer Latest Developments
Table 133. The Medicines Company Product Offered
Table 134. The Medicines Company Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 135. The Medicines Company Main Business
Table 136. The Medicines Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. The Medicines Company Latest Developments
Table 138. Daiichi Sankyo Product Offered
Table 139. Daiichi Sankyo Anticoagulants Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 140. Daiichi Sankyo Main Business
Table 141. Daiichi Sankyo Latest Developments
Table 142. Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Anticoagulants
Figure 2. Anticoagulants Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Anticoagulants Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Anticoagulants Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Platelet aggregation inhibitors (PAI)
Figure 7. Product Picture of Low-molecular-weight Heparin (LMWH)
Figure 8. Product Picture of Direct thrombin inhibitor (DTI)
Figure 9. Product Picture of Direct factor Xa inhibitors (DFXa)
Figure 10. Product Picture of Vitamin K antagonists (VKA)
Figure 11. Product Picture of Others
Figure 12. Global Anticoagulants Consumption Market Share by Type (2015-2020)
Figure 13. Global Anticoagulants Value Market Share by Type (2015-2020)
Figure 14. Anticoagulants Consumed in VTE
Figure 15. Global Anticoagulants Market: VTE (2015-2020) (K MT)
Figure 16. Global Anticoagulants Market: VTE (2015-2020) ($ Millions)
Figure 17. Anticoagulants Consumed in ACS/MI
Figure 18. Global Anticoagulants Market: ACS/MI (2015-2020) (K MT)
Figure 19. Global Anticoagulants Market: ACS/MI (2015-2020) ($ Millions)
Figure 20. Anticoagulants Consumed in AF
Figure 21. Global Anticoagulants Market: AF (2015-2020) (K MT)
Figure 22. Global Anticoagulants Market: AF (2015-2020) ($ Millions)
Figure 23. Anticoagulants Consumed in Other
Figure 24. Global Anticoagulants Market: Other (2015-2020) (K MT)
Figure 25. Global Anticoagulants Market: Other (2015-2020) ($ Millions)
Figure 26. Global Anticoagulants Consumption Market Share by Application (2015-2020)
Figure 27. Global Anticoagulants Value Market Share by Application (2015-2020)
Figure 28. Global Anticoagulants Sales Market Share by Company in 2017
Figure 29. Global Anticoagulants Sales Market Share by Company in 2019
Figure 30. Global Anticoagulants Revenue Market Share by Company in 2017
Figure 31. Global Anticoagulants Revenue Market Share by Company in 2019
Figure 32. Global Anticoagulants Sale Price by Company in 2019
Figure 33. Global Anticoagulants Consumption Market Share by Regions 2015-2020
Figure 34. Global Anticoagulants Value Market Share by Regions 2015-2020
Figure 35. Americas Anticoagulants Consumption 2015-2020 (K MT)
Figure 36. Americas Anticoagulants Value 2015-2020 ($ Millions)
Figure 37. APAC Anticoagulants Consumption 2015-2020 (K MT)
Figure 38. APAC Anticoagulants Value 2015-2020 ($ Millions)
Figure 39. Europe Anticoagulants Consumption 2015-2020 (K MT)
Figure 40. Europe Anticoagulants Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Anticoagulants Consumption 2015-2020 (K MT)
Figure 42. Middle East & Africa Anticoagulants Value 2015-2020 ($ Millions)
Figure 43. Americas Anticoagulants Consumption Market Share by Countries in 2019
Figure 44. Americas Anticoagulants Value Market Share by Countries in 2019
Figure 45. Americas Anticoagulants Consumption Market Share by Type in 2019
Figure 46. Americas Anticoagulants Consumption Market Share by Application in 2019
Figure 47. United States Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 48. United States Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 50. Canada Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 52. Mexico Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Anticoagulants Consumption Market Share by Countries in 2019
Figure 54. APAC Anticoagulants Value Market Share by Regions in 2019
Figure 55. APAC Anticoagulants Consumption Market Share by Type in 2019
Figure 56. APAC Anticoagulants Consumption Market Share by Application in 2019
Figure 57. China Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 58. China Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 60. Japan Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 62. Korea Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 64. Southeast Asia Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 65. India Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 66. India Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 68. Australia Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Anticoagulants Consumption Market Share by Countries in 2019
Figure 70. Europe Anticoagulants Value Market Share by Countries in 2019
Figure 71. Europe Anticoagulants Consumption Market Share by Type in 2019
Figure 72. Europe Anticoagulants Consumption Market Share by Application in 2019
Figure 73. Germany Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 74. Germany Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 75. France Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 76. France Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 77. UK Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 78. UK Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 80. Italy Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 82. Russia Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 83. Spain Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 84. Spain Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 85. Middle East & Africa Anticoagulants Consumption Market Share by Countries in 2019
Figure 86. Middle East & Africa Anticoagulants Value Market Share by Countries in 2019
Figure 87. Middle East & Africa Anticoagulants Consumption Market Share by Type in 2019
Figure 88. Middle East & Africa Anticoagulants Consumption Market Share by Application in 2019
Figure 89. Egypt Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 90. Egypt Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 91. South Africa Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 92. South Africa Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 93. Israel Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 94. Israel Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 95. Turkey Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 96. Turkey Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 97. GCC Countries Anticoagulants Consumption Growth 2015-2020 (K MT)
Figure 98. GCC Countries Anticoagulants Value Growth 2015-2020 ($ Millions)
Figure 99. Global Anticoagulants Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 100. Global Anticoagulants Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 101. Americas Anticoagulants Consumption 2021-2025 (K MT)
Figure 102. Americas Anticoagulants Value 2021-2025 ($ Millions)
Figure 103. APAC Anticoagulants Consumption 2021-2025 (K MT)
Figure 104. APAC Anticoagulants Value 2021-2025 ($ Millions)
Figure 105. Europe Anticoagulants Consumption 2021-2025 (K MT)
Figure 106. Europe Anticoagulants Value 2021-2025 ($ Millions)
Figure 107. Middle East & Africa Anticoagulants Consumption 2021-2025 (K MT)
Figure 108. Middle East & Africa Anticoagulants Value 2021-2025 ($ Millions)
Figure 109. United States Anticoagulants Consumption 2021-2025 (K MT)
Figure 110. United States Anticoagulants Value 2021-2025 ($ Millions)
Figure 111. Canada Anticoagulants Consumption 2021-2025 (K MT)
Figure 112. Canada Anticoagulants Value 2021-2025 ($ Millions)
Figure 113. Mexico Anticoagulants Consumption 2021-2025 (K MT)
Figure 114. Mexico Anticoagulants Value 2021-2025 ($ Millions)
Figure 115. Brazil Anticoagulants Consumption 2021-2025 (K MT)
Figure 116. Brazil Anticoagulants Value 2021-2025 ($ Millions)
Figure 117. China Anticoagulants Consumption 2021-2025 (K MT)
Figure 118. China Anticoagulants Value 2021-2025 ($ Millions)
Figure 119. Japan Anticoagulants Consumption 2021-2025 (K MT)
Figure 120. Japan Anticoagulants Value 2021-2025 ($ Millions)
Figure 121. Korea Anticoagulants Consumption 2021-2025 (K MT)
Figure 122. Korea Anticoagulants Value 2021-2025 ($ Millions)
Figure 123. Southeast Asia Anticoagulants Consumption 2021-2025 (K MT)
Figure 124. Southeast Asia Anticoagulants Value 2021-2025 ($ Millions)
Figure 125. India Anticoagulants Consumption 2021-2025 (K MT)
Figure 126. India Anticoagulants Value 2021-2025 ($ Millions)
Figure 127. Australia Anticoagulants Consumption 2021-2025 (K MT)
Figure 128. Australia Anticoagulants Value 2021-2025 ($ Millions)
Figure 129. Germany Anticoagulants Consumption 2021-2025 (K MT)
Figure 130. Germany Anticoagulants Value 2021-2025 ($ Millions)
Figure 131. France Anticoagulants Consumption 2021-2025 (K MT)
Figure 132. France Anticoagulants Value 2021-2025 ($ Millions)
Figure 133. UK Anticoagulants Consumption 2021-2025 (K MT)
Figure 134. UK Anticoagulants Value 2021-2025 ($ Millions)
Figure 135. Italy Anticoagulants Consumption 2021-2025 (K MT)
Figure 136. Italy Anticoagulants Value 2021-2025 ($ Millions)
Figure 137. Russia Anticoagulants Consumption 2021-2025 (K MT)
Figure 138. Russia Anticoagulants Value 2021-2025 ($ Millions)
Figure 139. Spain Anticoagulants Consumption 2021-2025 (K MT)
Figure 140. Spain Anticoagulants Value 2021-2025 ($ Millions)
Figure 141. Egypt Anticoagulants Consumption 2021-2025 (K MT)
Figure 142. Egypt Anticoagulants Value 2021-2025 ($ Millions)
Figure 143. South Africa Anticoagulants Consumption 2021-2025 (K MT)
Figure 144. South Africa Anticoagulants Value 2021-2025 ($ Millions)
Figure 145. Israel Anticoagulants Consumption 2021-2025 (K MT)
Figure 146. Israel Anticoagulants Value 2021-2025 ($ Millions)
Figure 147. Turkey Anticoagulants Consumption 2021-2025 (K MT)
Figure 148. Turkey Anticoagulants Value 2021-2025 ($ Millions)
Figure 149. GCC Countries Anticoagulants Consumption 2021-2025 (K MT)
Figure 150. GCC Countries Anticoagulants Value 2021-2025 ($ Millions)
Figure 151. Sanofi Anticoagulants Market Share (2018-2020)
Figure 152. Otsuka Anticoagulants Market Share (2018-2020)
Figure 153. Bayer Anticoagulants Market Share (2018-2020)
Figure 154. Johnson & Johnson Anticoagulants Market Share (2018-2020)
Figure 155. Genentech (Roche) Anticoagulants Market Share (2018-2020)
Figure 156. Boehringer Ingelheim Anticoagulants Market Share (2018-2020)
Figure 157. Aspen Anticoagulants Market Share (2018-2020)
Figure 158. AstraZeneca Anticoagulants Market Share (2018-2020)
Figure 159. Lilly Anticoagulants Market Share (2018-2020)
Figure 160. Bristol-Myers Squibb Anticoagulants Market Share (2018-2020)
Figure 161. Pfizer Anticoagulants Market Share (2018-2020)
Figure 162. The Medicines Company Anticoagulants Market Share (2018-2020)
Figure 163. Daiichi Sankyo Anticoagulants Market Share (2018-2020)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets